{"name":"Annexon, Inc.","slug":"annexon-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"ANX009","genericName":"ANX009","slug":"anx009","indication":"Other","status":"phase_1"},{"name":"ANX105","genericName":"ANX105","slug":"anx105","indication":"Other","status":"phase_1"},{"name":"ANX1502","genericName":"ANX1502","slug":"anx1502","indication":"Other","status":"phase_1"},{"name":"Tanruprubart","genericName":"Tanruprubart","slug":"tanruprubart","indication":"Other","status":"phase_3"},{"name":"Vonaprument","genericName":"Vonaprument","slug":"vonaprument","indication":"Other","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ANX007","genericName":"ANX007","slug":"anx007","indication":"Alzheimer's disease","status":"phase_2"}]}],"pipeline":[{"name":"ANX007","genericName":"ANX007","slug":"anx007","phase":"phase_2","mechanism":"ANX007 is an anti-Aβ oligomer antibody targeting the aggregation of amyloid-beta oligomers in the brain.","indications":["Alzheimer's disease"],"catalyst":""},{"name":"ANX009","genericName":"ANX009","slug":"anx009","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ANX105","genericName":"ANX105","slug":"anx105","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ANX1502","genericName":"ANX1502","slug":"anx1502","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tanruprubart","genericName":"Tanruprubart","slug":"tanruprubart","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Vonaprument","genericName":"Vonaprument","slug":"vonaprument","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPN0toQ2U2Q1BqcHBvOGdiak9kd0c0RFVwQkZ4bmJrY1BFS3dKTzBDOWlVcTMwc1FFS0lYMXhaT21keXh0cWhyRVl0eXpWdmpjZnM0VGItVmxYUF9qMkhvRTRBUmNfUUpvUDdYMm9YeU5DTERFU1VGNXJGNUkyb2dXMWNTXzBtUWdveHcwaVFvZTNKZWt1M3V6U29lRVc3YmlJMDdYYmo5VDY?oc=5","date":"2026-03-31","type":"deal","source":"GuruFocus","summary":"Annexon (ANNX) Gains Attention Amid Pharma Deal Activity - GuruFocus","headline":"Annexon (ANNX) Gains Attention Amid Pharma Deal Activity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxNa2c5RWVob0UwcGplR2dISkJpNldIUlJNdDRxRVU3aWdFNU4wcFVXcGd0SUVGa2QxdGJfdzNkbmp1Nlk5aVNZWlBWZE9MalY5UXhiaHFFTHljblpNMGdSejd5SUhSaFNTYjRqSVVaems0S3N6TU5jZ0pFWjFrcHBJbE5RbGtDUzBnaEZGeWN5Z1Q5MFlXRkNacDMwUV9tTVNPUnM3a21SRlFsajJaUVp6OFhwMWFrRWdWTFZDQlR2U2E4V01XLVhZVnZhd2tmeUp6QWZjdkh2azZodk9EdktCR1VVUWJFa0hLSU1OVG1TdWJxZHBaTWhNN2o1VF8yYjBCV2VuQWpXOGQ?oc=5","date":"2026-03-31","type":"pipeline","source":"Benzinga","summary":"Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving High - Benzinga","headline":"Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving High","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNUVQza3Y2SzVxME9mWGFhTl90eFhwNGdhQmFkelNGTmJDRklQWlVOYk1OTUEyQ3Q1TWxtMTNnZTlYUEg1Q05uQWdmSUJOdVFjVWRneE8wWi1WT1Fqa2FMZWJUTDI1RWl4ZkxXWWV1Q256MEN1UXVlZkVsblN4dDZEQ00tQ1FjU1dibDVpbEE4SS13b2hXbzlMNDhJQW1HN2l4TklnMldNclE0NVhlN2djRjVxMmt5MTUx?oc=5","date":"2026-03-31","type":"pipeline","source":"Investing.com Australia","summary":"Nvidia, Facebook among market cap stock movers on Tuesday By Investing.com - Investing.com Australia","headline":"Nvidia, Facebook among market cap stock movers on Tuesday By Investing.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPSXp3eGU1SlBPejZYWURTRFdNUFVKTE1Oc1J0TUdCOER3ZnduUFNtamtOSlNXS0Z0MVlhaU9paEZJVnZhbjJJeS1NUkk4VXdDZ0Y3ZlZIZTVtclYwMEdVNlJNS05sODE2Z09HY2JWc2JOSTNJNk9vRVQ2Rm5aaEVYd3pSTF83dWpQZlVNMGJLd2pfa1BSWUZFTGxHZVdUWmRt?oc=5","date":"2026-03-26","type":"pipeline","source":"BioWorld News","summary":"Corvus leads drug developers as index climbs in early 2026 - BioWorld News","headline":"Corvus leads drug developers as index climbs in early 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE51czNHN1dUa1E3Y19ERkJiVDJYOGdxUWNkQ0l4cG5hcWlzVW5mS0lBbHZhOTVPZWl4MzJIemUwUzhNMEZYcmJ3Nnd6dHJTcWVnTWF4WHhaeVlTSE9la3JYbG8wX1RmekR0bktYWEJR?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Annexon, Inc. (ANNX) - Stock Titan","headline":"If You Invested $1,000 in Annexon, Inc. (ANNX)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-19","type":"regulatory","source":"simplywall.st","summary":"Annexon (ANNX) Is Up 15.6% After EMA Filing For GBS Antibody Tanruprubart Has The Bull Case Changed? - simplywall.st","headline":"Annexon (ANNX) Is Up 15.6% After EMA Filing For GBS Antibody Tanruprubart Has The Bull Case Changed?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiTkFVX3lxTFBPQUszMW5kWjB0YTRaUEZEa1NtclFVNkV3ZUVsYk5ocFctRUZfeHZUX0loWUtleU85Rl9tX1Jwd1U2TXU3WndHTV9mTE5Ldw?oc=5","date":"2026-01-16","type":"earnings","source":"Stock Titan","summary":"Latest ANNX News - Annexon Reports Fourth Quarter and Year-End... - Stock Titan","headline":"Latest ANNX News - Annexon Reports Fourth Quarter and Year-End...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxNal9yb0poS19QYmQ1U3N3bGFzYXJ3VVFoNFZ1bFBEbWFTRGIwbmZOcVdqR0JaSWtsNjR1dVhjNzRaVFJLUzJBSDQtRUpha1VkNW9WSDdlY3pOd2FHeTRHXzhtUEZwMlJYSWFoWUhucWQ1eWdtTEkxNzR1MHlrSGpvUnBkZVE0ODlWQVpoRWhBS19iSUlXY3FsemVFd0xzV2RmOV91MUxSZ2NoWTFnNjFqQXF1QW83YzRTNDZlZ0FNYmZha1dGRjVNbzViMldQSXdyRXl6V1EtVmdRYlZOZHZuTnVQU2ZZR1NZQ0hqRmpuZkw1X09uRHMzd0duNlpOZlhULWMzRnVlajBBb3g0OWJYQnExeGNMc2ZqZHFuMld5YmFObkVMZFF0VXJLT3BpRVRFM3ZUS2Q4TGw4TDhLUUhGS1V4VU1kbS00Q0NR?oc=5","date":"2025-12-01","type":"pipeline","source":"GlobeNewswire","summary":"Geographic Atrophy Market to Surge Significantly During the - GlobeNewswire","headline":"Geographic Atrophy Market to Surge Significantly During the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQUEV4dm83dUhxTzJzNGEwRjB2SFZoOHdxRnhnNlAtVFhXODVib1MzMXdGTHE4SFVnN1NTcGJHQTgtOWJSOWFmb1FITzVLcjUtVDYteXI1bGl3b1cwRWotWE02OXpYRjBXZXc1MWdkV1I5NGNNblNrOFB2U0ZVc2l6R19pYlB5ak1tSW16TkN3d1VaSjN3MDN1OEQzLU5qRWlKTm9XakE1bw?oc=5","date":"2025-03-13","type":"pipeline","source":"seekingalpha.com","summary":"Annexon: Despite Major Catalysts, Stock Is Trading Almost At Cash (NASDAQ:ANNX) - seekingalpha.com","headline":"Annexon: Despite Major Catalysts, Stock Is Trading Almost At Cash (NASDAQ:ANNX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNcGo2bEROOTJCZWFiWDRiZGQ1QUlRUlY1RVNJbjhwNlNVOXVDYlhjc1Vwalk4ZWE3OExEaW1VUXZRNFcyc0F5R0M0dWZad3Nhc201YmtzdEsxR2VwY2ZZWGpOVW9YaGR1c3JkVDdhdlY3UXgyaWRsQmMzVEFhSWNmUXkyQm9FM0dHYjFVUHRPcjFidEdTZnZZ?oc=5","date":"2024-11-19","type":"pipeline","source":"Pharma Voice","summary":"The Dodgers’ World Series run brought attention to a rare disease. Annexon is stepping up to the plate. - Pharma Voice","headline":"The Dodgers’ World Series run brought attention to a rare disease. Annexon is stepping up to the plate.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNX3k2MGFFbU1OSDZaNW1mWW5iZHJWZmZLSkdnOXpuY0RvVEczYXY4U0NBNm9MQndNdEZHYU5OaFp4OEwtLXBnOEM1X0phRlh0LUtvRkxUdnNRUG40T1ltSVRtOEU3V1dNZGZsdGd1cjRzVkdNdzBBRG83UWx2U3dpd3dNTXdHWkpHbU9YRWI3UllLQU1xeFNkZm5LQWlqOHF4czByaEJtcVJDcGNFS2NBZzFhNGRuaEQxbmJhZUZ2bHFyS014MDJCb3BQbTY3dFE?oc=5","date":"2024-06-24","type":"trial","source":"2 Minute Medicine","summary":"Annexon Biosciences: ANX005 Antibody Shines in Phase 3 Trials For Treatment Of Guillain-Barré Syndrome - 2 Minute Medicine","headline":"Annexon Biosciences: ANX005 Antibody Shines in Phase 3 Trials For Treatment Of Guillain-Barré Syndrome - 2 Minute Medici","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQZHpUMWFQbmZCd1B6ZFR2ck5SUkJYd3RiQzNDYVY5VUhxYVdmUTdYNDRhVWg0MzIxZk1DYjR5V0o0c1dETVg2cERvYXczY0JQdkFHYm1lWDNRRE80d0FFYVJZRmRIRUN4MXZROWRJTXBKczVzRTZKdC12R1lNTjlXLWdmSzZrU04zTUZndDh2SnE5UQ?oc=5","date":"2023-05-25","type":"trial","source":"BioPharma Dive","summary":"Annexon claims a silver lining in failed eye drug study - BioPharma Dive","headline":"Annexon claims a silver lining in failed eye drug study","sentiment":"negative"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_2":1,"phase_1":3,"phase_3":2},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}